T cell receptor repertoire and function in patients with DiGeorge syndrome and velocardiofacial syndrome

Clinical and Experimental Immunology

Volumn 121, Issue 1, 2000, Pages 127-132

  Pierdominici, M ^a   Marziali, M ^a   Giovannetti, A ^a   Oliva, A ^a   Rosso, R ^a   Marino, B ^b   Digilio, M C ^b   Giannotti, A ^b   Novelli, G ^c   Dallapiccola, B ^c   Aiuti, F ^a   Pandolfi, F ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Apoptosis; DiGeorge syndrome; TCR repertoire; TCR signalling; Thymus; Velocardiofacial syndrome

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; T LYMPHOCYTE RECEPTOR;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMOSOME 22Q; CHROMOSOME DELETION; CLINICAL ARTICLE; DIGEORGE SYNDROME; FEMALE; HEART DISEASE; HUMAN; IMMUNE DEFICIENCY; INFANT; LYMPHOCYTE FUNCTION; MALE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VELOCARDIOFACIAL SYNDROME;

ABNORMALITIES, MULTIPLE; ANTIGENS, CD3; APOPTOSIS; CELL DIVISION; DIGEORGE SYNDROME; IMMUNOPHENOTYPING; MITOGENS; ONCOSTATIN M; PEPTIDES; PHOSPHORYLATION; PHYTOHEMAGGLUTININS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SYNDROME; T-LYMPHOCYTES; TYROSINE;

EID: 0033919852     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01247.x     Document Type: Article

References (44)

1. DiGeorge A. Congenital absence of the thymus and its immunologic consequences: concurrence with congenital hypoparathyroidism. In: Good RA, Bergsma D, eds. Immunologic deficiency diseases in man, Birth Defects Original Article Series. New York: New York National Foundation Press, 1968; 4:116-21.
2. Hong R. The DiGeorge anomaly. Immunodef Rev 1991; 3:1-14.
3. Driscoll DA, Budarf ML, Emanuel BS. A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11. Am J Hum Genet 1992; 50:924-33.
4. Carey AH, Kelly D, Halford S et al. Molecular genetic study of the frequency of monosomy 22q11 in DiGeorge syndrome. Am J Hum Genet 1992; 51:964-70.
5. Pizzuti A, Novelli G, Ratti A et al. UFD1L, a developmentally expressed ubiquitination gene, is deleted in CATCH 22 syndrome. Hum Mol Genet 1997; 6:259-65.
6. Novelli G, Mari A, Amati F et al. Structure and expression of the human ubiquitin fusion-degradation gene (UFD1L). Biochim Biophys Acta 1998; 1396:158-62.
7. Yamagishi H, Garg V, Matsuoka R, Thomas T, Srivastava D. A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects. Science 1999; 283:1158-61.
8. Driscoll DA, Spinner NB, Budarf ML et al. Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome. Am J Med Genet 1992; 44:261-8.
9. Driscoll AD, Salvin J, Sellinger B, Budarf ML, MacDonald-MacGinn DM, Zackai EH, Emanuel BS. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counseling and prenatal diagnosis. J Med Genet 1993; 30:813-7.
10. Kelly D, Goldberg R, Wilson D et al. Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11. Am J Med Genet 1993; 45:308-12.
11. Goldberg R, Motzkin B, Marion R, Scamber P, Shprintzen R. Velo-cardio-facial syndrome: a review of 120 patients. Am J Med Genet 1993; 45:313-9.
12. Wilson DI, Burn J, Scambler P, Goodship J. DiGeorge syndrome: part of CATCH 22. J Med Genet 1993; 30:852-6.
13. Daw S, Taylor C, Kramam M et al. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes. Nature Med 1996; 13:458-60.
14. Pignata C, D'Agostino A, Finelli P et al. Progressive deficiencies in blood T cells associated with a 10p12-13 interstitial deletion. Clin Immunol Immunopathol 1996; 80:9-15.
15. Muller W, Peter H, Kallfelz H, Franz A, Rieger C. The DiGeorge sequence. II. Immunologic findings in partial and complete forms of the disorder. Eur J Pediatr 1989; 149:96-103.
16. Radford DJ, Perkins L, Lachman R, Thong YH. Spectrum of Di George syndrome in patients with truncus arteriosus: expanded Di George syndrome. Pediatr Cardiol 1988; 9:95-101.
17. Slade HB, Greenwood JH, Beekman Rd McCoy JJ, Hudson JL, Pahwa S, Schwartz SA. Flow cytometric analysis of lymphocyte subpopulations in infants with congenital heart disease. J Clin Lab Anal 1989; 3:14-20.
18. Junker AK, Driscoll DA. Humoral immunity in DiGeorge syndrome. J Pediatr 1995; 127:231-7.
19. Rhoden DK, Leatherbury L, Helman S, Gaffney M, Strong WB, Guill MF. Abnormalities in lymphocyte populations in infants with neural crest cardiovascular defects. Pediatr Cardiol 1996; 17:143-9.
20. Gupta S, Aggarwal S, Nguyen T. Increased spontaneous apoptosis in T lymphocytes in DiGeorge anomaly. Clin Exp Immunol 1998; 113:65-71.
21. Collard HR, Boeck A, McLaughlin TM, Watson TJ, Schiff SE, Hale LP, Markert ML. Possible extrathymic development of nonfunctional T cells in a patient with complete DiGeorge syndrome. Clin Immunol 1999; 91:156-62.
22. MacDonald HR, Lees RD, Bron C, Sordat B, Meiescher G. T cell antigen receptor expression in athymic (nu/nu) mice. J Exp Med 1987; 166:195-209.
23. Sullivan KE, Jawad AF, Randall JP, Driscoll DA, Emanuel BS, McDonald-McGinn DM, Zackai EH. Lack of correlation between impaired T cell production, immunodeficiency and other phenotypic features in chromosome 22q11.2 deletion syndromes (DiGeorge syndrome/velocardiofacial syndrome). Clin Immunol Immunopathol 1998; 86:141-6.
24. Clegg C, Rulffes J, Wallace P, Haugen H. Regulation of an extrathymic T-cell development pathway by oncostatin M. Nature 1996; 384:261-3.
25. Metcalf D. Another way to generate T cells? Nature Med 1997; 3:18-19.
26. Pizzuti A, Novelli G, Mari A et al. Human homologue sequences to the Drosophila dishevelled segment-polarity gene are deleted in the DiGeorge syndrome. Am J Hum Genet 1996; 58:722-9.
27. Pandolfi F, Trentin L, San MI, Wong JT, Kurnick JT, Moscicki RA. T cell heterogeneity in patients with common variable immunodeficiency as assessed by abnormalities of T cell subpopulations and T cell receptor gene analysis. Clin Exp Immunol 1992; 89:198-203.
28. Hannet I, Erkeller-Yuksel F, Lydyard P, Deneys V, De Bruyere M. Lymphocyte populations as a function of age. Immunol Today 1992; 13:215-8.
29. Pandolfi F, Oliva A, Sacco G et al. Fibroblast-derived factors preserve viability in vitro of mononuclear cells isolated from subjects with HIV-1 infection. AIDS 1993; 7:323-9.
30. Pandolfi F, Pierdominici M, Oliva A et al. Apoptosis-related mortality in vitro of mononuclear cells from patients with HIV infection correlates with disease severity and progression. J AIDS 1995; 9:450-8.
31. Pandolfi F, Foa R, De Rossi G et al. Clonally expanded CD3+, CD4-, CD8- cells bearing the alpha/beta or the gamma/delta T-cell receptor in patients with the lymphoproliferative disease of granular lymphocytes. Clin Immunol Immunopathol 1991; 60:371-83.
32. Giovannetti A, Aiuti A, Pizzoli P et al. Tyrosine phosphorylation pathway is involved in interferon-gamma (IFN-γ) production; effect of sodium ortho vanadate. Clin Exp Immunol 1995; 100:157-63.
33. Bastian J, Law S, Volger L et al. Prediction of persistent immunodeficiency in the DiGeorge anomaly. J Pediatr 1989; 115:391-6.
34. Markert ML, Hummell DS, Rosenblatt HM et al. Complete DiGeorge syndrome: persistence of profound immunodeficiency. J Pediatr 1998; 132:15-21.
35. Markert ML, Kostyu DD, Ward FE et al. Successful formation of a chimeric human thymus allograft following transplantation of cultured postnatal human thymus. J Immunol 1997; 158:998-1005.
36. Markert ML, Boeck A, Hale LP et al. Transplantation of thymus tissue in complete DiGeorge syndrome. New Engl J Med 1999; 341:1180-9.
37. Pannetier C, Cochet M, Darche S, Casrouge A, Zoller M, Kourilski P. The sizes of the CDR3 hypervariable regions of the murine T cell receptor vary as a function of the recombined germ-line segments. Proc Natl Acad Sci USA 1993; 90:4319-23.
38. Maslanka K, Piatek T, Gorski J, Yassai M, Gorski J. Molecular analysis of T cell repertoires. Spectratypes generated by multiplex polymerase chain reaction and evaluated by radioactivity or fluorescence. Hum Immunol 1995; 44:28-34.
39. Shen J, Andrews DM, Pandolfi F et al. Oligoclonality of Vδ1 and Vδ2 cells in human peripheral blood mononuclear cells: TCR selection is not altered by stimulation with Gram-negative bacteria. J Immunol 1998; 160:3048-55.
40. Vissinga CS, Charmley P, Concannon P. Influence of coding region polymorphism on the peripheral expression of a human TCR V beta gene. J Immunol 1994; 152:1222-7.
41. Li Y, Szabo P, Robinson MA, Dong B, Posnett DN. Allelic variations in the human T cell receptor V beta 6.7 gene products. J Exp Med 1990; 171:221-30.
42. Posnett DN, Vissinga CS, Pambuccian C et al. Level of human TCRBV3S1 (V beta 3) expression correlates with allelic polymorphism in the spacer region of the recombination signal sequence. J Exp Med 1994; 179:1707-11.
43. McConkey D, Hartzell P, Chow S, Orrenius S, Jondal M. Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex. J Immunol 1989; 143:1801-6.
44. Kerr J, Wyllie A, Currie A. Apoptosis: a basic biological phenomenon with wide ranging implication in tissue kinetics. Br J Cancer 1972; 26:239-57.